Study shows potential of GE-067, GE Healthcare's [18F] labeled analogue of Pittsburgh Compound B (PIB) as a novel PET imaging agent for brain amyloid accumulation related to Alzheimer's disease. Two hour half-life of [18F] labeled ligand offers potential for greater accessibility to clinical centers.